Search Count: 215
![]() |
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Beta3-Residues At Positions 20 And 24
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Beta3-Residues At Positions 22 And 26
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Beta3-Residues At Positions 23 And 26
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Acpc Residues At Positions 22 And 26
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Acpc Residues At Positions 5 And 13, Beta3 Residue At Position 9
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Backbone Modification In The Ga Module Of Protein Pab: Acpc Residues At Positions 5 And 39, Beta3 Residue At Position 26
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2024-06-05 Classification: PROTEIN BINDING |
![]() |
Gb1 Structure Determination In Living Eukaryotic Cells By In-Cell Nmr Spectroscopy
Organism: Finegoldia magna
Method: SOLUTION NMR Release Date: 2019-01-23 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
![]() |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
![]() |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
![]() |
Organism: Mus musculus, Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-09-05 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
![]() |
Meditope Enabled Trastuzumab I83E Variant In Complex With (Ac) Cqfda(Ph)2Strrlrcggsk
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
![]() |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
![]() |
Crystal Structure Of I83E Meditope-Enabled Trastuzumab With Azido-Peg3-Meditope
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
![]() |
Organism: Homo sapiens, Staphylococcus aureus, Finegoldia magna
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2013-10-09 Classification: IMMUNE SYSTEM |
![]() |
Organism: Homo sapiens, Staphylococcus aureus, Finegoldia magna
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2013-10-09 Classification: IMMUNE SYSTEM Ligands: CL |
![]() |
Organism: Homo sapiens, Staphylococcus aureus, Finegoldia magna
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2013-10-09 Classification: IMMUNE SYSTEM |
![]() |
Organism: Finegoldia magna
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2009-03-03 Classification: IMMUNE SYSTEM Ligands: SO4 |




















